BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Biohaven Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$11.35+0.57 (+5.29%)
Close on Oct 19, 2026
- Market cap
- $1.71B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$4.60 (−28.84%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.71B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 139.89
- Dividend yield
- –
- Free cash flow yield
- -29.94%
Fundamentals
- Net income
- -$586.84M
- EPS, diluted
- -$4.64
- Free cash flow
- -$511.87M
- Book value per share
- $0.08
- Diluted shares
- 151M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Operating income
-$567.44M
Net income
-$586.84M
EPS, diluted
-$4.64
Free cash flow
-$511.87M
Reported periodTrailing twelve months